Si Bone Inc Quick Ratio (SIBN) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Si bone inc   (NASDAQ: SIBN)

Si Bone Inc 's Quick Ratio

SIBN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 1.2 below Si Bone Inc average.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Quick Ratio than Si Bone Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 729, from total ranking in the second quarter 2026 at 1201.

Explain Quick Ratio?
How much Cash & cash equivalents SIBN´s has?
What are SIBN´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SIBN/financial-strength
https://api.csimarket.com/api/v1/companies/SIBN/fundamentals
https://api.csimarket.com/api/v1/companies/SIBN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
SIBN Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 17.02 %
Y / Y Cash & cash equivalent Change 33.88 %
Quick Ratio MRQ 1.2
SIBN's Total Ranking # 729
Seq. Current Liabilities Change 23.2 %
Seq. Cash & cash equivalent Change -74.94 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 24
Healthcare Sector # 271
Overall Market # 729


Quick Ratio Statistics
High Average Low
14.58 5.16 1.05
(Dec 31 2020)   (Sep 30 2025)




Financial Statements
Si Bone Inc 's Current Liabilities $ 30 Millions Visit SIBN's Balance sheet
Si Bone Inc 's Cash & cash equivalent $ 35 Millions Visit SIBN's Balance sheet
Source of SIBN's Sales Visit SIBN's Sales by Geography


Cumulative Si Bone Inc 's Quick Ratio

SIBN's Quick Ratio for the trailling 12 Months

SIBN Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 1.05 %
Y / Y Cash & cash equivalent TTM Growth 84.8 %
Quick Ratio TTM 2.56
Total Ranking TTM # 3768
Seq. Current Liabilities TTM Growth 4.56 %
Seq. Cash & cash equivalent TTM Growth 3.68 %


On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2026 to $29.62 millions, cumulative Quick Ratio decreased to 2.56 above the SIBN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 196 other companies have achieved higher Quick Ratio than Si Bone Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2729 to 3768.

Explain Quick Ratio?
How much Cash & cash equivalents SIBN´s has?
What are SIBN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 197
Healthcare Sector # 876
Within the Market # 3768


trailing twelve months Quick Ratio Statistics
High Average Low
4.22 2.3 0.92
(Dec 31 2020)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Trisalus Life Sciences Inc   3.15 $ 41.057  Millions$ 13.014  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Carlsmed Inc   3.08 $ 56.207  Millions$ 18.237  Millions
Neuropace Inc   3.08 $ 49.431  Millions$ 16.070  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Streamex Corp   2.80 $ 26.248  Millions$ 9.382  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Vivani Medical Inc   2.22 $ 14.591  Millions$ 6.585  Millions
Electromed Inc   2.19 $ 15.875  Millions$ 7.261  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Aethlon Medical Inc   1.91 $ 6.487  Millions$ 3.403  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions

Date modified: 2026-11-04T15:25:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.